​

Funding Round

Seed Round - Thymmune Therapeutics

Seed Round - Thymmune Therapeutics

Investment Firm

Overview

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

Announced Date

Mar 01, 2023

Closed on Date

Mar 01, 2023

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

Pillar VC

Pillar VC

Pillar VC is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorPhilip Reilly
Participant InvestorGeorge Church
Participant InvestorMark Bamforth
Participant InvestorJohn Maraganore
Participant InvestorPillar VC

Round Details and Background

Thymmune Therapeutics raised $7000000 on 2023-03-01 in Seed Round

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2023
Seed Round - Thymmune Therapeutics
8-7.0M
Sep 29, 2023
Grant - Thymmune Therapeutics
1-37.0M

Recent Activity

There is no recent news or activity for this profile.